A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery

被引:333
作者
Chen, Mei-Chin [2 ]
Sonaje, Kiran [1 ]
Chen, Ko-Jie [1 ]
Sung, Hsing-Wen [1 ]
机构
[1] Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan
[2] Natl Cheng Kung Univ, Dept Chem Engn, Tainan, Taiwan
关键词
Bioavailability; Transcellular pathway; Paracellular pathway; Target delivery; Formulation technology; IN-VITRO EVALUATION; SOLID LIPID NANOPARTICLES; EPITHELIAL-CELLS CACO-2; HUMAN MUCUS BARRIER; DRUG-DELIVERY; INTESTINAL EPITHELIUM; PLGA NANOPARTICLES; PEPTIDE DELIVERY; VIVO EVALUATION; PEYERS-PATCHES;
D O I
10.1016/j.biomaterials.2011.08.087
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Success in the oral delivery of therapeutic insulin can significantly improve the quality of life of diabetic patients who must routinely receive injections of this drug. However, oral absorption of insulin is limited by various physiological barriers and remains a major scientific challenge. Various technological solutions have been developed to increase the oral bioavailability of insulin. Having received considerable attention, nano-sized polymeric particles are highly promising for oral insulin delivery. This review article describes the gastrointestinal barriers to oral insulin delivery, including chemical, enzymatic and absorption barriers. The potential transport mechanisms of insulin delivered by nanoparticles across the intestinal epithelium are also discussed. Finally, recent advances in using polymeric nanoparticles for oral insulin delivery and their effects on insulin transport are reviewed, along with their future. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:9826 / 9838
页数:13
相关论文
共 123 条
  • [1] Bioadhesive microdevices with multiple reservoirs: a new platform for oral drug delivery
    Ahmed, A
    Bonner, C
    Desai, TA
    [J]. JOURNAL OF CONTROLLED RELEASE, 2002, 81 (03) : 291 - 306
  • [2] Oral absorption of peptides through the cobalamin (vitamin B12) pathway in the rat intestine
    Alsenz, J
    Russell-Jones, GJ
    Westwood, S
    Levet-Trafit, B
    de Smidt, PC
    [J]. PHARMACEUTICAL RESEARCH, 2000, 17 (07) : 825 - 832
  • [3] Biodegradation and biocompatibility of PLA and PLGA microspheres
    Anderson, JM
    Shive, MS
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1997, 28 (01) : 5 - 24
  • [4] Predicting human oral bioavailability of a compound: Development of a novel quantitative structure-bioavailability relationship
    Andrews, CW
    Bennett, L
    Yu, LX
    [J]. PHARMACEUTICAL RESEARCH, 2000, 17 (06) : 639 - 644
  • [5] Arbit Ehud, 2004, Diabetes Technol Ther, V6, P510, DOI 10.1089/1520915041705929
  • [6] EFFECT OF CHITOSAN ON THE PERMEABILITY OF MONOLAYERS OF INTESTINAL EPITHELIAL-CELLS (CACO-2)
    ARTURSSON, P
    LINDMARK, T
    DAVIS, SS
    ILLUM, L
    [J]. PHARMACEUTICAL RESEARCH, 1994, 11 (09) : 1358 - 1361
  • [7] The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo
    Atuma, C
    Strugala, V
    Allen, A
    Holm, L
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2001, 280 (05): : G922 - G929
  • [8] BALCERZAK SP, 1970, GASTROENTEROLOGY, V58, P49
  • [9] In vitro evaluation of the potential of thiomers for the nasal administration of Leu-enkephalin
    Bernkop-Schnuerch, A.
    Obermair, K.
    Greimel, A.
    Palmberger, T. F.
    [J]. AMINO ACIDS, 2006, 30 (04) : 417 - 423
  • [10] The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins
    Bernkop-Schnurch, A
    [J]. JOURNAL OF CONTROLLED RELEASE, 1998, 52 (1-2) : 1 - 16